Guido Moll

Co-Principle Investigator & Deputy Group Leader at Charité Universitätsmedizin Berlin

Speaker

Translational scientist with focus in immunology, regenerative medicine, stem cell biology / cell therapy, and novel systems biology approaches to better connect the different scientific fields. Currently CoPI on DFG/NCN-funded project EXPAND-PD “Antagonizing detrimental cytokine signaling and angiogenesis to expand access and duration of peritoneal dialysis treatment” at Charité. Prior Assistant Scientific Coordinator for EU-H2020-ATMP/GMP projects (e.g. PACE, HIPGEN, ONE Study) at the BIH Center for Regenerative Therapies (BCRT), Charité Univ. Medicine Berlin, Germany. PhD and Postdoc studies on improving the safety and efficacy of various ATMPs at Karolinska Institutet, Stockholm, Sweden and Charité Univ. Medicine Berlin, Germany. Diploma studies on adoptive T-cell therapies at Queensland Institute of Medical Research (QIMR), Brisbane, Australia. Engineering Diploma in Medical Biotechnology from University of Technology in Berlin (TUB), Berlin, Germany.